Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
GENCONCOR-1 study is translational research aimed to investigate the concordance of the molecular genetic profile of the primary tumor and brain metastases (BM) of colorectal cancer (CRC). The study was conducted by post hoc analysis of pairs of samples of histological material with determination of the mutational status of genes KRAS, NRAS, BRAF, HER2 and MSI.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Potwierdzony histologicznie rak jelita grubego lub odbytnicy
- •Potwierdzony histologicznie przerzut do mózgu
- •Przeprowadzona operacja usunięcia przerzutu z mózgu
- •Dostępne próbki zarówno pierwotnego nowotworu jak i tkanki z mózgu
✗ Disqualifies
- •Brakuje jednej z dwóch próbek do porównania
- •Niewystarczająca jakość próbki lub zbyt mało materiału do badania genetycznego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 5, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Blokhin's Russian Cancer Research Center
Moscow, Russia
Trial contact
David Halafyan, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/6/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.